Médipôle Lyon-Villeurbanne
9
5
7
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
OPTIMUM Study of Remote Patient Monitoring in Ambulatory Heart Failure Care
Role: lead
Intradialytic Exercise With Blood Flow Restriction in Hemodialysis Patients
Role: collaborator
Rehabilitation of Taste and Smell Disorders Associated With Chemotherapy Using Aromatherapy
Role: lead
Improvement of Nutritional Status in Cancer Patients and Reduction of Malnutrition
Role: lead
French COhoRte Extra-Vascular Implantable CardiovErter DefibrillatoR
Role: collaborator
Evaluation of the Metabolic Surgery Technique for Glycemic Improvement in Type 2 Diabetes
Role: lead
Registry of Management Strategies for Patients With COVID-19 in Healthcare Establishments
Role: collaborator
French Cohort Evaluating the effectiveneSs of Atrioventricular Synchrony by the micRa AV
Role: collaborator
Evaluation of the POSOS Device for Iatrogenesis Detection in Clinical History? A Vignettes Study
Role: collaborator
All 9 trials loaded